ClinicalTrials.gg
Not yet recruitingNCT07910461SUNRISE-ORTHOUpdated Nov 3, 2026

Orthognathic Surgery and Obstructive Sleep Apnea Assessed by Mandibular Jaw Movement Monitoring (SUNRISE-ORTHO)

An observational study in Obstructive Sleep Apnea, Sleep Apnea, Obstructive and Dentofacial Deformities, sponsored by CHR Sambre et Meuse Site Meuse. Not yet recruiting at 1 site in Belgium. Open to participants aged 15 Years and older. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by CHR Sambre et Meuse Site Meuse · Observational

Updated Nov 3, 2026Eligibility revisedPrimary outcomes revised+1 moreGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
25
Ages
15 Years and older
Sex
All
01

Study summary

Orthognathic surgery changes the skeletal framework of the upper airway, but its functional effect on sleep-disordered breathing remains poorly documented, particularly with respect to respiratory effort. This prospective, exploratory, single-center pilot study will describe changes in the apnea-hypopnea index (AHI) and in respiratory effort burden (REMOV, percentage of total sleep time with increased respiratory effort) measured with the Sunrise mandibular jaw movement (MJM) home sleep monitoring device, from 1 month before to 6 months after orthognathic surgery (bilateral sagittal split osteotomy with or without Le Fort I osteotomy). Twenty-five patients aged 15 years or older, scheduled for orthognathic surgery as part of standard care at CHR Sambre et Meuse (Namur, Belgium) and screened positive for sleep-disordered breathing risk, will be included. Results will be used to generate hypotheses and to size a future confirmatory study.

Read the detailed description

Design: prospective, exploratory, single-center, non-randomized cohort without control group. Surgery is indicated and performed as part of standard care and is not assigned by the protocol; the study adds standardized measurements before and after surgery. Screening and inclusion (two steps): (1) STOP-BANG score >= 3 and/or high risk on the Berlin questionnaire; (2) only if step 1 is positive, a first Sunrise night at 1 month before surgery (T-1 month), considered positive if AHI >= 5 events/h OR REMOV >= 15% of total sleep time. Both steps must be positive for inclusion. The 15% REMOV threshold is an operational screening threshold chosen for this study and is not a validated cut-off. Schedule: T-1 month: virtual surgical planning (IPS CaseDesigner) from intraoral scans, facial multidetector CT in natural head position, clinical parameters, two consecutive Sunrise nights and questionnaires (STOP-BANG, Berlin, ESS, FSS, FOSQ-10, SF-12, EQ-5D-5L). Day 0: bilateral sagittal split osteotomy with or without Le Fort I osteotomy, mandible-first sequence, single surgeon. Postoperative visits at 1 week and 4 weeks. T+6 months: facial CT in natural head position, postoperative virtual analysis, two consecutive Sunrise nights and the same questionnaires. Sample size: 25 participants, based on pilot study recommendations (Sim \& Lewis; Whitehead et al.). Assuming a mean AHI change of about 5 events/h and a standard deviation of 7 events/h, 25 patients provide a 95% confidence interval of approximately +/- 3 events/h around the mean change. Analysis: descriptive and exploratory; paired comparisons between T-1 month and T+6 months; exploratory association between surgical movements and changes in AHI/REMOV. Data are collected on paper source documents and a pseudonymized Excel database at the study site.

02

Conditions studied

  • Obstructive Sleep Apnea
  • Sleep Apnea, Obstructive
  • Dentofacial Deformities

Keywords

  • orthognathic surgery
  • bilateral sagittal split osteotomy
  • Lefort 1 osteotomy
  • home sleep apnea testing
  • respiratory effort
  • apnea-hypopnea index
  • mandibular jaw movement
  • upper airway volume
03

In context

Sleep Apnea, Obstructive

2,271 studies on the registry are indexed under Sleep Apnea, Obstructive; 472 are open to participants now.

This study's planned enrollment of 25 is below the median of 103 across 671 observational studies indexed under Sleep Apnea, Obstructive.

Browse Sleep Apnea, Obstructive studies →

Lead sponsor

This is the only study on the registry with CHR Sambre et Meuse Site Meuse as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

The criteria were revised on the registry on Nov 3, 2026. See what changed

Ages eligible
15 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients aged 15 years or older referred to the maxillofacial surgery department of CHR Sambre et Meuse, Meuse site (Namur, Belgium), and scheduled for orthognathic surgery after orthodontic-surgical multidisciplinary assessment.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Dentoskeletal deformity requiring bilateral sagittal split osteotomy with or without Le Fort I osteotomy after orthodontic-maxillofacial multidisciplinary assessment.
  • Age 15 years or older at consent, with completed skeletal growth according to department practice.
  • Positive two-step screening for sleep-disordered breathing risk: (1) STOP-BANG score >= 3 and/or high risk on the Berlin questionnaire; and (2) on the first Sunrise night at 1 month before surgery, AHI >= 5 events/h or REMOV >= 15% of total sleep time.
  • Signed informed consent (co-signed by holders of parental authority for minors). - Ability to use the Sunrise device at home.

Exclusion criteria

Exclusion Criteria:

  • Medical or anesthetic contraindication to orthognathic surgery.
  • Known severe sleep-disordered breathing (AHI >= 30/h) treated preoperatively with CPAP or a mandibular advancement device.
  • Syndromic craniofacial malformation (e.g., Crouzon syndrome, Pierre Robin sequence).
  • Known allergy or skin intolerance to the Sunrise sensor materials or adhesive, or active dermatosis of the submental area.
  • Current pregnancy or breastfeeding.
  • Concurrent participation in another interventional study likely to interfere with sleep measurements or surgical outcomes.
  • Inability to comply with the planned visits and procedures.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
25 participants (estimated)
Patient registry
No

Groups and cohorts

  • Orthognathic surgery cohort

    Patients aged 15 years or older scheduled for bilateral sagittal split osteotomy with or without Le Fort I osteotomy as part of standard care, with positive two-step screening for sleep-disordered breathing risk. Sunrise monitoring (2 nights) and facial CT are performed 1 month before and 6 months after surgery.

    Procedure: Orthognathic surgery (BSSO with or without Le Fort I osteotomy) · Device: Sunrise mandibular jaw movement monitoring · Diagnostic Test: Facial multidetector CT in natural head position

Interventions

  • ProcedureOrthognathic surgery (BSSO with or without Le Fort I osteotomy)

    Standard-of-care orthognathic surgery under general anesthesia, mandible-first sequence, planned with 3D virtual surgical planning (IPS CaseDesigner, KLS Martin) and in-house printed splints. Not assigned by the study protocol.

  • DeviceSunrise mandibular jaw movement monitoring

    Chin-mounted MJM sensor (Sunrise, Namur, Belgium) used at home for two consecutive nights before surgery and two consecutive nights 6 months after surgery to derive respiratory and sleep indices.

  • Diagnostic testFacial multidetector CT in natural head position

    Facial CT at 1 month before and 6 months after surgery for 3D upper airway volume analysis; field restricted to the facial skeleton, dose optimized.

06

What researchers measure

Primary outcomes

  1. Change in apnea-hypopnea index (AHI) measured by mandibular jaw movement monitoring

    AHI (events/h) measured with the Sunrise device; absolute change (T+6 months minus T-1 month) and relative change (%). Only absolute change is reported if baseline AHI \< 1 event/h.

    Time frame: From 1 month before surgery (baseline) to 6 months after surgery

  2. Change in respiratory effort burden (REMOV)

    Percentage of total sleep time with increased respiratory effort (REMOV, %TST) measured with the Sunrise device; absolute change (percentage points) and relative change (%). Only absolute change is reported if baseline REMOV \< 5% TST.

    Time frame: From 1 month before surgery (baseline) to 6 months after surgery

Secondary outcomes

  1. Change in Oxygen Desaturation Index (ODI)

    Number of oxygen desaturation events per hour of sleep (events/h), recorded during home sleep testing with the Sunrise system. This is a physiological index, not a scale score; higher values indicate more severe nocturnal hypoxemia (worse outcome).

    Time frame: From 1 month before surgery (baseline) to 6 months after surgery.

  2. Change in Respiratory Effort-Related Arousal (RERA) Index

    Number of respiratory effort-related arousals per hour of sleep (events/h), derived from mandibular jaw movement analysis by the Sunrise system. This is a physiological index, not a scale score; higher values indicate worse sleep-disordered breathing.

    Time frame: From 1 month before surgery (baseline) to 6 months after surgery.

  3. Change in Sleep Onset Latency

    Time from lights-off to sleep onset (minutes), measured by the Sunrise system. Not a scale score; higher values indicate worse sleep initiation.

    Time frame: From 1 month before surgery (baseline) to 6 months after surgery.

  4. Change in Wake After Sleep Onset (WASO)

    Total time awake after sleep onset (minutes), measured by the Sunrise system. Not a scale score; higher values indicate worse sleep continuity.

    Time frame: From 1 month before surgery (baseline) to 6 months after surgery.

  5. Change in Sleep Fragmentation Index

    Number of awakenings and sleep-stage shifts per hour of sleep (events/h), measured by the Sunrise system. Not a scale score; higher values indicate more fragmented sleep (worse outcome).

    Time frame: From 1 month before surgery (baseline) to 6 months after surgery.

  6. Change in STOP-BANG Questionnaire Score

    STOP-BANG questionnaire (Snoring, Tiredness, Observed apnea, high blood Pressure, Body mass index, Age, Neck circumference, Gender). Total score ranges from 0 to 8; higher scores indicate a higher risk of obstructive sleep apnea (worse outcome).

    Time frame: From 1 month before surgery (baseline) to 6 months after surgery.

  7. Percentage of Participants Classified as High Risk on the Berlin Questionnaire

    Berlin Questionnaire for sleep apnea risk, with three symptom categories; participants are classified as high risk if two or more categories are positive. Reported as the percentage of participants at high risk; a higher percentage indicates a worse outcome.

    Time frame: From 1 month before surgery (baseline) to 6 months after surgery.

  8. Correlation Between Mandibular Advancement and Change in AHI

    Spearman's rank correlation coefficient between (1) achieved mandibular anteroposterior advancement in millimeters, measured at B point by superimposition of preoperative and 6-month postoperative facial CT scans in IPS CaseDesigner, and (2) change in apnea-hypopnea index (events/h) measured by the Sunrise system between baseline and 6 months.

    Time frame: From 1 month before surgery (baseline) to 6 months after surgery.

  9. Correlation Between Maxillary Advancement and Change in AHI

    Spearman's rank correlation coefficient between (1) achieved maxillary anteroposterior advancement in millimeters, measured at B point by superimposition of preoperative and 6-month postoperative facial CT scans in IPS CaseDesigner, and (2) change in apnea-hypopnea index (events/h) measured by the Sunrise system between baseline and 6 months.

    Time frame: From 1 month before surgery (baseline) to 6 months after surgery.

  10. Correlation Between Mandibular Advancement and Change in REMOV

    Spearman's rank correlation coefficient between (1) achieved mandibular anteroposterior advancement in millimeters, measured at B point by superimposition of preoperative and 6-month postoperative facial CT scans in IPS CaseDesigner, and (2) change in percentage of total sleep time with increased respiratory effort (REMOV, %) measured by the Sunrise system between baseline and 6 months.

    Time frame: From 1 month before surgery (baseline) to 6 months after surgery.

  11. Correlation Between Maxillary Advancement and Change in REMOV

    Spearman's rank correlation coefficient between (1) achieved maxillary anteroposterior advancement in millimeters, measured at B point by superimposition of preoperative and 6-month postoperative facial CT scans in IPS CaseDesigner, and (2) change in percentage of total sleep time with increased respiratory effort (REMOV, %) measured by the Sunrise system between baseline and 6 months.

    Time frame: From 1 month before surgery (baseline) to 6 months after surgery.

07

Study locations

1 site
  • CHR Sambre et Meuse - Site Meuse, Avenue Albert Ier 185, Namur, 5000, Belgium
    Namur, Namur 5100, Belgium
08

References and documents

Publications

  • Zaghi S, Holty JE, Certal V, Abdullatif J, Guilleminault C, Powell NB, Riley RW, Camacho M. Maxillomandibular Advancement for Treatment of Obstructive Sleep Apnea: A Meta-analysis. JAMA Otolaryngol Head Neck Surg. 2016 Jan;142(1):58-66. doi: 10.1001/jamaoto.2015.2678. PubMed 26606321 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared outside the study team, in accordance with the informed consent and the EU General Data Protection Regulation. Aggregated results will be published.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Jun 2027, 7 months later.

Of 259 non-industry observational studies under Sleep Apnea, Obstructive, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 60. This study's planned 7 months is below that.

Counting every sponsor, half of 294 studies reached it within 30 months; a quarter within 15 and three quarters within 61.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 27, 2026
First posted
Nov 2, 2026
StartEst.
Nov 4, 2026
Primary completionEst.
Jun 15, 2027
CompletionEst.
Sep 15, 2027
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Eligibility
1 inclusion criterion edited, 3 added; 7 exclusion criteria added, 1 removed
What changed in the criteria
Inclusion criteria
  • AddedDentoskeletal deformity requiring bilateral sagittal split osteotomy with or without Le Fort I osteotomy after orthodontic-maxillofacial multidisciplinary assessment.
  • AddedAge 15 years or older at consent, with completed skeletal growth according to department practice.
  • Edited- Dentoskeletal deformity requiring bilateral sagittal split osteotomy with or without Le Fort I osteotomy after orthodontic-maxillofacial multidisciplinary assessment. - Age 15 years or older at consent, with completed skeletal growth according to department practice. - Positive two-step screening for sleep-disordered breathing risk: (1) STOP-BANG score >= 3 and/or high risk on the Berlin questionnaire; and (2) on the first Sunrise night at 1 month before surgery, AHI >= 5 events/h or REMOV >= 15% of total sleep time. - Signed informed consent (co-signed by holders of parental authority for minors). - Ability to use the Sunrise device at home.
  • AddedSigned informed consent (co-signed by holders of parental authority for minors). - Ability to use the Sunrise device at home.
Exclusion criteria
  • Removed- Medical or anesthetic contraindication to orthognathic surgery. - Known severe sleep-disordered breathing (AHI >= 30/h) treated preoperatively with CPAP or a mandibular advancement device. - Syndromic craniofacial malformation (e.g., Crouzon syndrome, Pierre Robin sequence). - Known allergy or skin intolerance to the Sunrise sensor materials or adhesive, or active dermatosis of the submental area. - Current pregnancy or breastfeeding. - Concurrent participation in another interventional study likely to interfere with sleep measurements or surgical outcomes. - Inability to comply with the planned visits and procedures.
  • AddedMedical or anesthetic contraindication to orthognathic surgery.
  • AddedKnown severe sleep-disordered breathing (AHI >= 30/h) treated preoperatively with CPAP or a mandibular advancement device.
  • AddedSyndromic craniofacial malformation (e.g., Crouzon syndrome, Pierre Robin sequence).
  • AddedKnown allergy or skin intolerance to the Sunrise sensor materials or adhesive, or active dermatosis of the submental area.
  • AddedCurrent pregnancy or breastfeeding.
  • AddedConcurrent participation in another interventional study likely to interfere with sleep measurements or surgical outcomes.
  • AddedInability to comply with the planned visits and procedures.
Nov 3, 2026
Primary outcomes
8 removed
What changed in the outcomes
  • RemovedChange in oxygen desaturation index (ODI)Time frame: From 1 month before surgery (baseline) to 6 months after surgery
  • RemovedChange in time with oxygen saturation below 90% (T90)Time frame: From 1 month before surgery (baseline) to 6 months after surgery
  • RemovedChange in respiratory effort-related arousal (RERA) indexTime frame: From 1 month before surgery (baseline) to 6 months after surgery
  • RemovedChange in sleep fragmentation, sleep latency and wake after sleep onset (WASO)Time frame: From 1 month before surgery (baseline) to 6 months after surgery
  • RemovedChange in STOP-BANG score and Berlin questionnaire risk categoryTime frame: From 1 month before surgery (baseline) to 6 months after surgery
  • RemovedChange in upper airway volumesTime frame: From 1 month before surgery (baseline) to 6 months after surgery
  • RemovedFeasibility and tolerance of Sunrise monitoringTime frame: From 1 month before surgery (baseline) to 6 months after surgery
  • RemovedAssociation between surgical skeletal movements and changes in AHI and REMOVTime frame: From 1 month before surgery to 6 months after surgery
Nov 3, 2026
Secondary outcomes
11 added
What changed in the outcomes
  • AddedChange in Oxygen Desaturation Index (ODI)Time frame: From 1 month before surgery (baseline) to 6 months after surgery.
  • AddedChange in Respiratory Effort-Related Arousal (RERA) IndexTime frame: From 1 month before surgery (baseline) to 6 months after surgery.
  • AddedChange in Sleep Onset LatencyTime frame: From 1 month before surgery (baseline) to 6 months after surgery.
  • AddedChange in Wake After Sleep Onset (WASO)Time frame: From 1 month before surgery (baseline) to 6 months after surgery.
  • AddedChange in Sleep Fragmentation IndexTime frame: From 1 month before surgery (baseline) to 6 months after surgery.
  • AddedChange in STOP-BANG Questionnaire ScoreTime frame: From 1 month before surgery (baseline) to 6 months after surgery.
  • AddedPercentage of Participants Classified as High Risk on the Berlin QuestionnaireTime frame: From 1 month before surgery (baseline) to 6 months after surgery.
  • AddedCorrelation Between Mandibular Advancement and Change in AHITime frame: From 1 month before surgery (baseline) to 6 months after surgery.
  • AddedCorrelation Between Maxillary Advancement and Change in AHITime frame: From 1 month before surgery (baseline) to 6 months after surgery.
  • AddedCorrelation Between Mandibular Advancement and Change in REMOVTime frame: From 1 month before surgery (baseline) to 6 months after surgery.
  • AddedCorrelation Between Maxillary Advancement and Change in REMOVTime frame: From 1 month before surgery (baseline) to 6 months after surgery.
Nov 3, 2026
Registered
First appeared on the registry
Nov 2, 2026
Show all 2 updates
  1. Nov 3, 2026
    Eligibility 1 inclusion criterion edited, 3 added; 7 exclusion criteria added, 1 removed
    What changed in the criteria
    Inclusion criteria
    • AddedDentoskeletal deformity requiring bilateral sagittal split osteotomy with or without Le Fort I osteotomy after orthodontic-maxillofacial multidisciplinary assessment.
    • AddedAge 15 years or older at consent, with completed skeletal growth according to department practice.
    • Edited- Dentoskeletal deformity requiring bilateral sagittal split osteotomy with or without Le Fort I osteotomy after orthodontic-maxillofacial multidisciplinary assessment. - Age 15 years or older at consent, with completed skeletal growth according to department practice. - Positive two-step screening for sleep-disordered breathing risk: (1) STOP-BANG score >= 3 and/or high risk on the Berlin questionnaire; and (2) on the first Sunrise night at 1 month before surgery, AHI >= 5 events/h or REMOV >= 15% of total sleep time. - Signed informed consent (co-signed by holders of parental authority for minors). - Ability to use the Sunrise device at home.
    • AddedSigned informed consent (co-signed by holders of parental authority for minors). - Ability to use the Sunrise device at home.
    Exclusion criteria
    • Removed- Medical or anesthetic contraindication to orthognathic surgery. - Known severe sleep-disordered breathing (AHI >= 30/h) treated preoperatively with CPAP or a mandibular advancement device. - Syndromic craniofacial malformation (e.g., Crouzon syndrome, Pierre Robin sequence). - Known allergy or skin intolerance to the Sunrise sensor materials or adhesive, or active dermatosis of the submental area. - Current pregnancy or breastfeeding. - Concurrent participation in another interventional study likely to interfere with sleep measurements or surgical outcomes. - Inability to comply with the planned visits and procedures.
    • AddedMedical or anesthetic contraindication to orthognathic surgery.
    • AddedKnown severe sleep-disordered breathing (AHI >= 30/h) treated preoperatively with CPAP or a mandibular advancement device.
    • AddedSyndromic craniofacial malformation (e.g., Crouzon syndrome, Pierre Robin sequence).
    • AddedKnown allergy or skin intolerance to the Sunrise sensor materials or adhesive, or active dermatosis of the submental area.
    • AddedCurrent pregnancy or breastfeeding.
    • AddedConcurrent participation in another interventional study likely to interfere with sleep measurements or surgical outcomes.
    • AddedInability to comply with the planned visits and procedures.
    Primary outcomes 8 removed
    What changed in the outcomes
    • RemovedChange in oxygen desaturation index (ODI)Time frame: From 1 month before surgery (baseline) to 6 months after surgery
    • RemovedChange in time with oxygen saturation below 90% (T90)Time frame: From 1 month before surgery (baseline) to 6 months after surgery
    • RemovedChange in respiratory effort-related arousal (RERA) indexTime frame: From 1 month before surgery (baseline) to 6 months after surgery
    • RemovedChange in sleep fragmentation, sleep latency and wake after sleep onset (WASO)Time frame: From 1 month before surgery (baseline) to 6 months after surgery
    • RemovedChange in STOP-BANG score and Berlin questionnaire risk categoryTime frame: From 1 month before surgery (baseline) to 6 months after surgery
    • RemovedChange in upper airway volumesTime frame: From 1 month before surgery (baseline) to 6 months after surgery
    • RemovedFeasibility and tolerance of Sunrise monitoringTime frame: From 1 month before surgery (baseline) to 6 months after surgery
    • RemovedAssociation between surgical skeletal movements and changes in AHI and REMOVTime frame: From 1 month before surgery to 6 months after surgery
    Secondary outcomes 11 added
    What changed in the outcomes
    • AddedChange in Oxygen Desaturation Index (ODI)Time frame: From 1 month before surgery (baseline) to 6 months after surgery.
    • AddedChange in Respiratory Effort-Related Arousal (RERA) IndexTime frame: From 1 month before surgery (baseline) to 6 months after surgery.
    • AddedChange in Sleep Onset LatencyTime frame: From 1 month before surgery (baseline) to 6 months after surgery.
    • AddedChange in Wake After Sleep Onset (WASO)Time frame: From 1 month before surgery (baseline) to 6 months after surgery.
    • AddedChange in Sleep Fragmentation IndexTime frame: From 1 month before surgery (baseline) to 6 months after surgery.
    • AddedChange in STOP-BANG Questionnaire ScoreTime frame: From 1 month before surgery (baseline) to 6 months after surgery.
    • AddedPercentage of Participants Classified as High Risk on the Berlin QuestionnaireTime frame: From 1 month before surgery (baseline) to 6 months after surgery.
    • AddedCorrelation Between Mandibular Advancement and Change in AHITime frame: From 1 month before surgery (baseline) to 6 months after surgery.
    • AddedCorrelation Between Maxillary Advancement and Change in AHITime frame: From 1 month before surgery (baseline) to 6 months after surgery.
    • AddedCorrelation Between Mandibular Advancement and Change in REMOVTime frame: From 1 month before surgery (baseline) to 6 months after surgery.
    • AddedCorrelation Between Maxillary Advancement and Change in REMOVTime frame: From 1 month before surgery (baseline) to 6 months after surgery.
  2. Nov 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07910461
Lead sponsor
CHR Sambre et Meuse Site Meuse
Responsible party
Decaux Jerome (MD, Maxillofacial Surgeon, Principal Investigator, CHR Sambre et Meuse Site Meuse) — Principal investigator
First posted
Nov 2, 2026
Start date
Nov 4, 2026 (estimated)
Primary completion
Jun 15, 2027 (estimated)
Completion
Sep 15, 2027 (estimated)
Last update
Nov 3, 2026

Study contacts

Jerome Decaux, MD
Contact
jerome.decaux@chrsm.be
0032474523674
jerome decaux, MD
principal investigator · CHR Sambre et Meuse - Site Meuse, Avenue Albert Ier 185, Namur, 5000, Belgium

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion